[go: up one dir, main page]

CO5251448A1 - Soluciones que contienen epinastina - Google Patents

Soluciones que contienen epinastina

Info

Publication number
CO5251448A1
CO5251448A1 CO00085787A CO00085787A CO5251448A1 CO 5251448 A1 CO5251448 A1 CO 5251448A1 CO 00085787 A CO00085787 A CO 00085787A CO 00085787 A CO00085787 A CO 00085787A CO 5251448 A1 CO5251448 A1 CO 5251448A1
Authority
CO
Colombia
Prior art keywords
containing epinastine
solution
solution according
possibly
solutions containing
Prior art date
Application number
CO00085787A
Other languages
English (en)
Inventor
Trach Volker
Duschler Gerold
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5251448(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of CO5251448A1 publication Critical patent/CO5251448A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
    • F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/0318—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)

Abstract

Solución acuosa aplicable por vía tópica que contiene epinastina, eventualmente en forma de su racemato, sus enantiómeros, así como eventualmente en forma de sus sales por adición de ácidos farmacológicamente inocuas, en una concentración de 0,005 a 0,5 mg/ml de solución. Solución según la reivindicación 1 que contiene hidrocloruro de epinastina. Solución según una de las reivindicaciones 1 ó 2, caracterizada porque es ajustada a un valor del pH comprendido entre 6,5 y 7,2 mediante un tampón fisiológicamente compatible. Solución según la reivindicación 3, caracterizada porque contiene además un agente de conservación. Utilización de una de las soluciones según una de las reivindicaciones 1 a 4 para la inhibición de la afluencia de neutrófilos y eosinófilos en el tejido de Ia conjuntiva del ojo o en el de la mucosa nasal.
CO00085787A 1999-11-12 2000-11-10 Soluciones que contienen epinastina CO5251448A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19954516A DE19954516A1 (de) 1999-11-12 1999-11-12 Epinastin-haltige Lösungen

Publications (1)

Publication Number Publication Date
CO5251448A1 true CO5251448A1 (es) 2003-02-28

Family

ID=7928843

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00085787A CO5251448A1 (es) 1999-11-12 2000-11-10 Soluciones que contienen epinastina

Country Status (40)

Country Link
US (6) US20030050303A1 (es)
EP (1) EP1231920B1 (es)
JP (1) JP2003514021A (es)
KR (1) KR100758842B1 (es)
CN (1) CN1292752C (es)
AR (1) AR026424A1 (es)
AT (1) ATE353218T1 (es)
AU (2) AU784017B2 (es)
BG (1) BG65775B1 (es)
BR (1) BR0015477A (es)
CA (1) CA2391076C (es)
CO (1) CO5251448A1 (es)
CY (1) CY1106375T1 (es)
CZ (1) CZ302483B6 (es)
DE (2) DE19954516A1 (es)
DK (1) DK1231920T3 (es)
EA (1) EA006937B1 (es)
EE (1) EE05395B1 (es)
ES (1) ES2281359T3 (es)
HK (1) HK1052303B (es)
HR (1) HRP20020404B1 (es)
HU (1) HU229502B1 (es)
IL (2) IL149501A0 (es)
ME (1) MEP36708A (es)
MX (1) MXPA02004556A (es)
MY (1) MY130441A (es)
NO (1) NO329417B1 (es)
NZ (1) NZ519425A (es)
PE (1) PE20010826A1 (es)
PL (1) PL198879B1 (es)
PT (1) PT1231920E (es)
RS (1) RS50173B (es)
SA (1) SA01210658B1 (es)
SI (1) SI1231920T1 (es)
SK (1) SK287343B6 (es)
TR (1) TR200201270T2 (es)
TW (1) TWI225401B (es)
UA (1) UA74563C2 (es)
WO (1) WO2001035962A1 (es)
ZA (1) ZA200203683B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
JP2006501211A (ja) * 2002-08-02 2006-01-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング エピナスチン、プソイドエフェドリン及びメチルエフェドリンの組み合せを含有する医薬組成物
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
JP2009500397A (ja) * 2005-07-08 2009-01-08 千寿製薬株式会社 エピナスチンを含む眼科用経皮吸収型製剤
WO2008098122A2 (en) * 2007-02-08 2008-08-14 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20080194544A1 (en) * 2007-02-08 2008-08-14 Ramesh Krishnamoorthy Aqueous formulations of epinastine for treating allergic rhinitis
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20120203161A1 (en) * 2009-08-12 2012-08-09 Seros Medical, Llc Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method of use
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
MX368876B (es) * 2012-12-19 2019-10-21 Sarcode Bioscience Inc Formulaciones del inhibidor del antígeno-1 asociado a la función de linfocitos (lfa-1).
CN104491876A (zh) * 2014-12-23 2015-04-08 中国药科大学 含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) * 2015-09-28 2017-03-28 Tred Srl Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6635974B2 (ja) * 2017-04-24 2020-01-29 参天製薬株式会社 エピナスチン含有点眼液
TW201841620A (zh) * 2017-05-01 2018-12-01 日商參天製藥股份有限公司 點眼劑
JP2019108320A (ja) * 2018-10-31 2019-07-04 参天製薬株式会社 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP7599838B2 (ja) * 2019-04-10 2024-12-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性医薬組成物
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP6963651B2 (ja) 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液
JP7114668B2 (ja) * 2020-10-08 2022-08-08 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US104017A (en) * 1870-06-07 Improvement in embroidering attachment for sewing-machines
US203021A (en) * 1878-04-30 Improvement in side-bar wagons
US151541A (en) * 1874-06-02 Improvement in hay-loaders
US181478A (en) * 1876-08-22 Improvement in water-wheels
US8632A (en) * 1852-01-06 George hess
US228359A (en) * 1880-06-01 jones
US215396A (en) * 1879-05-13 Improvement in loom-temples
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
TW537903B (en) * 1995-06-27 2003-06-21 Boehringer Ingelheim Kg New stable pharmaceutical preparation for producing propellant gas-free aerosols
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
AU3869197A (en) * 1996-08-30 1998-03-19 Kyoto Pharmaceutical Industries, Ltd. Remedies for allergic dermatitis
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
EP1242090A4 (en) * 1999-11-18 2004-02-11 Alcon Inc USE OF AN H1 ANTAGONIST AND A SAFE STEROID IN THE TREATMENT OF EYE CONDITIONS
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
WO2002098112A2 (en) * 2001-05-29 2002-12-05 Transchip, Inc. Patent application cmos imager for cellular applications and methods of using such
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
US6863848B2 (en) * 2002-08-30 2005-03-08 Signet Armorlite, Inc. Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) * 2005-10-27 2007-06-14 Nissan Motor Co Ltd 遮光装置とサンバイザーとサンルーフユニット

Also Published As

Publication number Publication date
HRP20020404B1 (hr) 2007-08-31
CN1292752C (zh) 2007-01-03
DK1231920T3 (da) 2007-04-10
AR026424A1 (es) 2003-02-12
US20070197503A1 (en) 2007-08-23
US7429602B2 (en) 2008-09-30
IL149501A (en) 2012-04-30
SA01210658B1 (ar) 2006-11-05
HK1052303B (zh) 2007-04-13
US20030050303A1 (en) 2003-03-13
US20050288274A1 (en) 2005-12-29
EA200200492A1 (ru) 2002-10-31
NO329417B1 (no) 2010-10-18
AU2006201541A1 (en) 2006-05-11
EP1231920B1 (de) 2007-02-07
EE200200246A (et) 2003-06-16
WO2001035962A1 (de) 2001-05-25
US20070185082A1 (en) 2007-08-09
CA2391076C (en) 2008-06-17
CZ20021956A3 (cs) 2002-08-14
DE19954516A1 (de) 2001-05-17
CN1390129A (zh) 2003-01-08
EP1231920A1 (de) 2002-08-21
ZA200203683B (en) 2003-09-03
CY1106375T1 (el) 2011-10-12
DE50014041D1 (de) 2007-03-22
BG106681A (en) 2002-12-29
HRP20020404A2 (en) 2004-08-31
HUP0203773A2 (hu) 2003-03-28
PL198879B1 (pl) 2008-07-31
IL149501A0 (en) 2002-11-10
NO20022201D0 (no) 2002-05-08
TWI225401B (en) 2004-12-21
ATE353218T1 (de) 2007-02-15
PL364028A1 (en) 2004-11-29
HUP0203773A3 (en) 2005-01-28
CA2391076A1 (en) 2001-05-25
KR100758842B1 (ko) 2007-09-19
BR0015477A (pt) 2002-06-25
NZ519425A (en) 2004-04-30
NO20022201L (no) 2002-05-08
BG65775B1 (bg) 2009-11-30
CZ302483B6 (cs) 2011-06-08
US20090239842A1 (en) 2009-09-24
AU784017B2 (en) 2006-01-12
MEP36708A (en) 2011-02-10
EA006937B1 (ru) 2006-06-30
TR200201270T2 (tr) 2002-12-23
PT1231920E (pt) 2007-03-30
HU229502B1 (en) 2014-01-28
ES2281359T3 (es) 2007-10-01
UA74563C2 (uk) 2006-01-16
US20080009476A1 (en) 2008-01-10
SK287343B6 (sk) 2010-07-07
RS50173B (sr) 2009-05-06
MXPA02004556A (es) 2004-09-10
MY130441A (en) 2007-06-29
HK1052303A1 (en) 2003-09-11
AU1138101A (en) 2001-05-30
PE20010826A1 (es) 2001-08-20
EE05395B1 (et) 2011-04-15
SI1231920T1 (sl) 2007-06-30
SK8302002A3 (en) 2002-09-10
JP2003514021A (ja) 2003-04-15
KR20020050273A (ko) 2002-06-26
YU33602A (sh) 2005-03-15

Similar Documents

Publication Publication Date Title
CO5251448A1 (es) Soluciones que contienen epinastina
CO5190689A1 (es) Sales de tramadol formadas por tramadol y un edulcorante y formas farmaceuticas que contienen dichas sales
BRPI0407845A (pt) formulação intranasal de rotigotina
AR102101A2 (es) Formulación y método de complejo de aripiprazol
LU93066I2 (fr) Combinaison de a) olodatérol, isomèrers optiques individuels de celui-ci, melanges d'énantionmères indiviou de recémates, leurs sels d'addition d'acide avec des acides pharmaceutiquement acceptables, éventuellement sous forme de solvates et/ou hycrates, et b.) un sel de tiotropium ; en particulier une combinaison de a) olodatérol et sis sels d'addition d'acide avec des acides pharmaceutiquement acceptables et b.) du bromure de tiotropium, éventuellement sous forme de solvate et/ou hydrate , plus particulièrement une combinaison de a) hadrochlorure d'olodatérol et b.) de bromure de tiotropium, éventuellement sous forme de monohydrate
BRPI0014869B8 (pt) prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
DE60104872D1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
ATA2332000A (de) Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
CO5180582A1 (es) Soluciones farmaceuticas de levosimendan
AR082049A1 (es) Formulaciones liquidas de rupatadina fumarato
AR034817A1 (es) Barra de detergente mejorada y procedimiento de fabricacion
PE20010127A1 (es) Suspension de ziprasidona
ECSP044979A (es) Uso de bibn4096 en combinación con otros fármacos antimigrañosos para el tratamiento de migraña
AR039977A1 (es) Composicion a base de diclofenac para el tratamiento topico de afecciones de la cavidad orofaringea
AR041069A1 (es) Composicion de tolterodina liquida oral
BR0013651A (pt) Tratamento de enxaqueca pela administração de ácido alfalipóico ou seus derivados
AR034975A1 (es) Metodo para el tratamiento del insomnio primario
AR043536A1 (es) Composicion farmaceutica que comprende acido 5-metil-2-(2´-cloro-6´-fluoroanilino)fenilacetico
DK1019037T3 (da) Lægemiddel indeholdende delta-aminolevulinsyre
AR044697A1 (es) Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato
AR047438A1 (es) Sal amina de derivado de carboestirilo
ES2181415T3 (es) Composicion acuosa ionica que contiene levomentol.
AR035416A1 (es) Una composicion farmaceutica esteril y el metodo para prepararla
AR040001A1 (es) Formulaciones de bisfosfonatos de uso inyectable
RU2000105080A (ru) Препарат для лечения гриппа

Legal Events

Date Code Title Description
FC Application refused